Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. patents novel LXR-beta agonists

May 7, 2018

Dong-A Socio Holdings identifies Mer inhibitors

May 4, 2018

RTI International discovers new APLNR agonists

May 4, 2018

Jiangsu Hengrui Medicine and collaborator disclose TGFR-1 inhibitors

May 4, 2018

AbbVie divulges novel BRD4 inhibitors

May 4, 2018

Bristol-Myers Squibb presents new apelin receptor agonists

May 4, 2018

Heptares Therapeutics divulges novel M1 and/or M4 receptor agonists

May 3, 2018

Novel mutant IDH inhibitors presented by Isocure Biosciences

May 3, 2018

TES Pharma discovers ACMSD inhibitors

May 3, 2018

Mission Therapeutics patents USP30 inhibitors

May 3, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...